Related Experiment Video
Updated: Feb 7, 2026

An Experimental Analysis of Children's Ability to Provide a False Report about a Crime
Published on: May 3, 2016
Suspected adverse drug reactions reported for Brazilian children: cross-sectional study
Elisangela da Costa Lima1, Guacira Corrêa de Matos1, Jean M de L Vieira2
1Universidade Federal do Rio de Janeiro, Faculdade de Farmácia, Observatório de Vigilância e Uso de Medicamentos, Rio de Janeiro, RJ, Brazil.
Insights
Adverse drug reactions in Brazilian children (0-12 years) were analyzed from 2008-2013. Serious events and off-label use were noted, highlighting the need for safer medication practices in pediatrics.
Area of Science:
- Pediatric Pharmacology
- Pharmacovigilance
- Public Health
Background:
- Adverse drug reactions (ADRs) pose a significant risk to pediatric populations.
- Monitoring ADRs is crucial for ensuring medication safety in children.
- Understanding ADR patterns in specific regions, like Brazil, is essential for targeted interventions.
Purpose of the Study:
- To analyze spontaneous reports of suspected adverse drug reactions in children aged 0-12 years in Brazil.
- To identify trends in ADRs, including demographics, suspected drugs, and outcomes.
- To provide data that can inform regulatory actions and improve pediatric medication safety.
Main Methods:
- A cross-sectional study analyzed ADR reports from the Brazilian Health Regulatory Agency (2008-2013).
- Data included report year, origin, child's gender and age, suspected drug, reaction description, and seriousness.
- Comparisons were made with pediatric bed data and global VigiBase data.
Main Results:
- 3330 ADRs were reported in children; 54% were in boys.
- 28% of reports involved infants (0-1 year); 40% originated from the Southeast region.
- 60% of ADRs were serious, with 75 deaths; nearly 30% of deaths involved off-label drug use. Anti-infectives and nervous system drugs were frequently implicated.
Conclusions:
- ADR report distribution by sex and age aligns with hospitalized pediatric populations in Brazil.
- Findings on ADR seriousness and implicated drugs can guide regulatory actions.
- The study underscores the importance of improving safe medication use in children.
Objective:
To assess spontaneous reports of suspected adverse drug reactions in children aged 0-12 years from the Brazilian Health Regulatory Agency between 2008 and 2013.
Methods:
A cross-sectional study on suspected adverse drug reactions reports related to medicines and health products in children was carried out for a six-year period (2008-2013). Year of report, origin of report by Brazilian state, gender, age, suspected drug, adverse reaction description and seriousness were included in the analysis. The data obtained was compared to the number of pediatric beds in health services and to global data from the VigiBase (World Health Organization).
Results:
A total of 3330 adverse drug reactions were reported in children in Brazil in the investigated period (54% were in boys). About 28% of suspected adverse drug reactions reports involved 0 to 1-year-old children. Almost 40% of reports came from the Southeast region. Approximately 60% were classified as serious events. There was death in 75 cases. Nearly 30% of deaths involved off-label use; 3875 medicines (465 active substances) were considered suspected drugs. Anti-infective (vancomycin, ceftriaxone, oxacillin, and amphotericin), nervous system (metamizole) and alimentary tract and metabolism medicines were more frequent in reports.
Conclusions:
The distribution of suspected adverse drug reactions reports by sex and age group corresponded to the profile of children hospitalized in Brazil. Data about seriousness and medicines reported may be useful to encourage regulatory actions and improve the safe use of medicines in children.
Related Concept Videos
Cross-Sectional Research
Finding Volume Using Cross-Sectional Area
Profile Leveling and Cross Sections
Drug Dosing: Infants and Children
Crossed Aldol Reactions: Overview
Spinal Cord: Cross-sectional Anatomy
Gray Matter and its Components
Central to the gray matter is...

